Mitsutoshi Kato Selected Research

ipragliflozin

8/2017

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsutoshi Kato Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2004
5	Hypertension (High Blood Pressure) 01/2024 - 01/2014
4	Body Weight (Weight, Body) 01/2021 - 02/2009
2	Essential Hypertension 01/2024 - 01/2014
2	Obesity 09/2021 - 02/2019
1	Hyperkalemia 01/2023
1	Hypotension (Low Blood Pressure) 01/2021
1	Insulin Resistance 01/2021
1	COVID-19 01/2020
1	Diabetes Mellitus 04/2019
1	Heart Failure 04/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2019
1	Weight Loss (Weight Reduction) 02/2019

Drug/Important Bio-Agent (IBA)

4	SaltsIBA 01/2024 - 10/2004
4	Angiotensin Receptor AntagonistsIBA 01/2024 - 04/2019
4	SodiumIBA 01/2024 - 01/2014
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 02/2019
3	dapagliflozinIBA 01/2021 - 02/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2019
2	esaxerenoneIBA 01/2024 - 01/2023
2	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 04/2019
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2024 - 01/2023
2	PotassiumIBA 01/2024 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 04/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2019
2	empagliflozinIBA 01/2021 - 04/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	ORALIT (ORS)IBA 09/2021
1	Uric Acid (Urate)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 04/2019
1	VitaminsIBA 02/2019
1	CarbohydratesIBA 02/2019
1	LipidsIBA 08/2017
1	ipragliflozinIBA 08/2017
1	VildagliptinIBA 02/2009
1	MagnesiumIBA 10/2004

Therapy/Procedure

4	Therapeutics 09/2021 - 08/2017
3	Glycemic Control 01/2020 - 02/2009